News stories about Mead Johnson Nutrition CO (NYSE:MJN) have trended somewhat positive this week, according to Accern. The research group ranks the sentiment of news coverage by reviewing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Mead Johnson Nutrition CO earned a media sentiment score of 0.08 on Accern’s scale. Accern also assigned news coverage about the company an impact score of 46.9012346871539 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
These are some of the news articles that may have effected Accern Sentiment Analysis’s scoring:
- Baby Food and Infant Formula Market Predicted to Rake in (Revenues) during 2015 – 2021 (mynewsdesk.com)
- Learn details of the infant milk formula market (whatech.com)
- Infant Formula Market to Grow at 10.1% CAGR Through 2026 (mynewsdesk.com)
- Global Medical Nutrition Market Status and Forecast 2022 – Abbott Nutrition, Baxter International, Mead Johnson Nutrition (sbwire.com)
- Baxter International : Global Medical Nutrition Market Status and Forecast 2022 – Abbott Nutrition, Baxter International, Mead Johnson Nutrition (4-traders.com)
MJN has been the topic of several recent analyst reports. BMO Capital Markets reissued a “hold” rating and issued a $90.00 price objective on shares of Mead Johnson Nutrition CO in a research note on Thursday, June 15th. BidaskClub raised Mead Johnson Nutrition CO from a “sell” rating to a “hold” rating in a research note on Wednesday, June 14th. Finally, Canaccord Genuity reissued a “speculative buy” rating on shares of Mead Johnson Nutrition CO in a research note on Wednesday, July 5th. Two equities research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. Mead Johnson Nutrition CO currently has an average rating of “Hold” and a consensus price target of $83.18.
Shares of Mead Johnson Nutrition CO (NYSE MJN) traded down 0.01% during trading on Monday, hitting $89.98. The stock had a trading volume of 11,923,467 shares. The company’s 50 day moving average price is $89.62 and its 200 day moving average price is $84.34. Mead Johnson Nutrition CO has a 52 week low of $69.25 and a 52 week high of $94.40.
About Mead Johnson Nutrition CO
Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.
Receive News & Ratings for Mead Johnson Nutrition CO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition CO and related companies with MarketBeat.com's FREE daily email newsletter.